Ratings by Stifel (Benjamin J. Burnett)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/10/2025 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 12/13/2024 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/23/2024 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 10/1/2024 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 6/27/2024 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 4/4/2024 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Buy (N/A) |
|
Details | ||
| 10/16/2023 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 9/25/2023 | Repare Therapeutics | RPTX | Maintain | Buy (N/A) |
|
Details | ||
| 8/10/2023 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Buy (N/A) |
|
Details | ||
| 7/28/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 6/9/2023 | Repare Therapeutics | RPTX | Upgrade | Buy (Hold) |
11.92 (2.65) |
-77.77% | Details | |
| 5/25/2023 | eFFECTOR Therapeutics, Inc. | EFTR | Upgrade | Buy (Hold) |
0.69 (0.18) |
-73.91% | Details | |
| 5/11/2023 | Repare Therapeutics | RPTX | Maintain | Hold (N/A) |
|
Details | ||
| 3/9/2023 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 1/6/2023 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Hold (N/A) |
|
Details | ||
| 11/8/2022 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 6/22/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (Buy) |
|
Details | ||
| 6/8/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (Buy) |
|
Details | ||
| 6/6/2022 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Hold (Hold) |
|
Details | ||
| 6/2/2022 | Repare Therapeutics | RPTX | Maintain | Hold (Hold) |
|
Details | ||
| 5/11/2022 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Hold (N/A) |
|
Details | ||
| 4/29/2022 | Genocea Biosciences | GNCA | Downgrade | Hold (Buy) |
0.41 (0.05) |
-87.8% | Details | |
| 4/12/2022 | Repare Therapeutics | RPTX | Downgrade | Hold (Buy) |
10.37 (2.65) |
-74.45% | Details | |
| 4/11/2022 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/16/2022 | eFFECTOR Therapeutics, Inc. | EFTR | Maintain | Hold (Hold) |
|
Details | ||
| 3/16/2022 | Precision BioSciences Inc. | DTIL | Maintain | Buy (Buy) |
|
Details | ||
| 3/9/2022 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 3/3/2022 | Repare Therapeutics | RPTX | Maintain | Buy (Buy) |
|
Details | ||
| 1/25/2022 | eFFECTOR Therapeutics, Inc. | EFTR | Downgrade | Buy (Hold) |
6.03 (0.18) |
-97.01% | Details | |
| 12/13/2021 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 11/11/2021 | Repare Therapeutics | RPTX | New Coverage | Buy (N/A) |
26.21 (2.65) |
-89.89% | Details | |
| 11/10/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2021 | eFFECTOR Therapeutics, Inc. | EFTR | Upgrade | Buy (Hold) |
10.47 (6.03) |
-42.41% | Details | |
| 11/4/2021 | Sangamo BioSciences | SGMO | Maintain | Hold (N/A) |
|
Details | ||
| 10/13/2021 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 10/4/2021 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 9/9/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 8/9/2021 | Dicerna Pharmaceuticals | DRNA | Maintain | Hold (N/A) |
|
Details | ||
| 8/9/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 7/30/2021 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 5/13/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 4/20/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 4/16/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 4/15/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 3/29/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 3/17/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 3/10/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 3/2/2021 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 3/1/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 2/26/2021 | Precision BioSciences Inc. | DTIL | Maintain | Buy (N/A) |
|
Details | ||
| 2/17/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 1/12/2021 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 12/8/2020 | bluebird bio | BLUE | Maintain | Hold (N/A) |
|
Details | ||
| 12/7/2020 | Atara Biotherapeutics | ATRA | Maintain | Buy (N/A) |
|
Details | ||
| 11/5/2020 | bluebird bio | BLUE | Downgrade | Hold (Buy) |
58.55 (4.97) |
-91.51% | Details | |
| 10/28/2020 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 10/21/2020 | CRISPR Therapeutics | CRSP | Maintain | Hold (N/A) |
|
Details | ||
| 8/6/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 5/13/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details | ||
| 5/11/2020 | bluebird bio | BLUE | Maintain | Buy (N/A) |
|
Details |
